Authorship, "the state or fact of being the writer of a book, article, or document, or the creator of a work of art,"1 derives from the word author, auctor, autour, autor "father, creator, one who brings about, one who makes or creates," from Old French auctor, acteor "author, originator, creator, instigator," directly from the Latin auctor "promoter, doer; responsible person, teacher," literally "one who causes to grow."2  It implies a creative privilege and responsibility that cannot be taken lightly.  In the biomedical arena, the International Committee of Medical Journal Editors (ICMJE) "recommends that authorship be based on the following four criteria: 1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND 2. Drafting the work or revising it critically for important intellectual content; AND 3. Final approval of the version to be published; AND 4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy and integrity of any part of the work are appropriately investigated and resolved."3

 

Thus, all persons designated as authors should qualify for authorship, and all those who qualify as authors should be so listed.3 The first of these general principles means that all persons listed as authors should meet the four ICMJE criteria for authorship; the second principle means that all those who meet the four ICMJE criteria for authorship should be listed as authors.3 The first part of the statement disqualifies honorific "gift" authors, complementary "guest" authors, and anonymous "ghost" authors from being listed as authors. The second part ensures the listing of all those who qualify as authors, even if they are no longer part of the institution or group from which the work emanates (such as students who have graduated or residents and fellows who have completed their postgraduate training).

 

Honorific or "gift" authorship takes place when a subordinate (or junior) person lists a superior (or senior) person as an author, even if that person did not meet the four ICMJE authorship criteria.4,5 Bestowing the gift on a Chief, Chair, Department Head, Director, Dean, or such other person is often done in gratitude, but carries an unspoken expectation that the favor will be returned in the future. It can also be bestowed under coercive conditions (that may overlap with those of guest authorship discussed next).4.5 It is unethical because the gifted person does not qualify for authorship when at most only acknowledgement is his or her due. In the extreme, such a person can be put in the uncomfortable and embarrassing situation of being unable to comment on the supposedly co-authored work when asked to do so. Moreover, the unqualified co-author(s) may actually attempt to wash their hands of any allegations of misconduct, claiming for example that the resident first author "plagiarized the material" or "fabricated or manipulated the data" but "I/we certainly had nothing to do with that" - - hence the fourth criterion for authorship came to be.3 Reviewers and Editors may suspect "gift" authorship when for instance, a resident listed as first author writes the paper in the first person, using the pronoun "I" instead of "we" and thanks the consultant co-author under the "acknowledgements" section. The suspicions are further reinforced when the concerned co-author(s) do not participate in, or contribute to revising the manuscript critically for important intellectual content during the review and editing process.

 

Guest authorship takes place when influential or well-known individuals "lend" their name to a manuscript to boost its prestige, even though they had nothing to do with its creation.6,7 They may have been invited to do so by one or more of the actual authors, but they willingly agree, considering the arrangement mutually-beneficial. Thus, a student or resident may knowingly invite an adviser or consultant to be listed as co-author, even if the latter did not meet authorship criteria. The former perceives that having a known co-author increases the chances of a favorable review and publication; the latter effectively adds another publication to his or her curriculum vitae. It is not difficult to see how such symbioses may thrive in the "publish or perish" milieu of academe. Research advising alone, even if editing of the research paper was performed, do not qualify one for authorship (Cf. "gift" authorship). This is not to say that a research, thesis or dissertation adviser may not be listed as co-author - as long as he or she meets the 4 ICMJE criteria for authorship.3 A related misconduct is the practice by certain persons with seniority of insisting their names be listed first, even if more junior scholars did all the innovative thinking and research on a project. Indeed, the order of authorship can be a source of unhappiness and dispute. Authors be listed in the order of their contributions to the work - the one who contributed most is listed first, and the order of listing should be a joint decision of all co-authors at the start of the study (reviewed periodically).

 

Ghost authorship usually pertains to paid professional writers who anonymously produce material that is officially attributed to another author.7,8 They may operate out of establishments that manufacture term papers, theses, and dissertations for the right price (such as the infamous C.M. Recto district in downtown Manila, now replaced by numerous online services). They may also be employed by the pharmaceutical industry to write promotional, favorable studies that will list well-known persons (professors, scientists, senior clinicians) as authors, often with consent and adequate compensation.8 Examples include "a professor at the University of Wisconsin" being paid "$1,500 in return for putting his name" on "an article on the 'therapeutic effects' of their diet pill Redux (dexfenfluramine)," that was "pulled from the market" a year later "as doctors began reporting heart-valve injuries in as many as one-third of patients taking the drug" and the drug "later linked to dozens of deaths."9 Similar cases involved the "deadly drug" rofecoxib (Vioxx) "eventually blamed for some 60,000+ deaths," that "was also linked to a number of shameful scandals relating to fraudulent studies and the use of ghostwriters to boost sales."9 The costs involved are not meager; Parke-Davis paid "a medical education communication company (MECC) to write articles in support of the drug" Neurontin (gabapentin) "to the tune of $13,000 to $18,000 per article. In turn, MECC paid $1,000 each to friendly physicians and pharmacists to sign off as authors of the articles."9 Pfizer (who acquired Neurontin form Parke-Davis) "was found guilty of illegally promoting off-label uses of Neurontin," and "fined more than $142 million in damages."9 Whether or not morbidities or mortalities ensue from the practice, both ghosts and beneficiary-authors should be held liable in such situations.

 

Clearly, the practice of "gift," "guest," and "ghost" authorship should not be entertained by authors or tolerated by editors and reviewers. Authorship should be based on the ICMJE authorship criteria. Our editors and reviewers vigilantly strive to uphold and protect the rights and welfare of our authors and the integrity and soundness of their research. We call on all fellows, diplomates and residents in training to do the same.

Human ; Authorship ; Authorship Standards ; Trends ; Ethics ; Gift Authorship ; Guest Authorship ; Ghost Authorship

No abstract available.
*Authorship ; *Editorial Policies ; Guideline Adherence/standards ; Korea ; Ownership/*standards ; Peer Review, Research/*standards ; Periodicals as Topic/*standards ; Writing/*standards

Citations to scholarly items are building bricks for multidisciplinary science communication. Citation analyses are currently influencing individual career advancement and ranking of academic and research institutions worldwide. This article overviews the involvement of scientific authors, reviewers, editors, publishers, indexers, and learned associations in the citing and referencing to preserve the integrity of science communication. Authors are responsible for thorough bibliographic searches to select relevant references for their articles, comprehend main points, and cite them in an ethical way. Reviewers and editors may perform additional searches and recommend missing essential references. Publishers, in turn, are in a position to instruct their authors over the citations and references, provide tools for validation of references, and open access to bibliographies. Publicly available reference lists bear important information about the novelty and relatedness of the scholarly items with the published literature. Few editorial associations have dealt with the issue of citations and properly managed references. As a prime example, the International Committee of Medical Journal Editors (ICMJE) issued in December 2014 an updated set of recommendations on the need for citing primary literature and avoiding unethical references, which are applicable to the global scientific community. With the exponential growth of literature and related references, it is critically important to define functions of all stakeholders of science communication in curbing the issue of irrational and unethical citations and thereby improve the quality and indexability of scholarly journals.
Authorship/standards ; *Bibliography as Topic ; *Editorial Policies ; Information Dissemination/ethics ; Peer Review, Research/ethics/*standards ; Periodicals as Topic/ethics/*standards ; Publishing/ethics/*standards ; Quality Control ; Science/ethics/standards ; Writing/*standards

In 2010, Chinese Pharmacopoeia Committee officially enacted Chinese Pharmacopoeia (2010 edition). The Volume 1 of the pharmacopoeia is comprised of the medicinal materials and the decoction pieces, the essential oils and extracts of medicinal plants, prescription preparations and single preparation, etc., which not only provides Latin names of Chinese medicinal materials, also provided Latin names of the original medicinal plants to effectively control the quality of Chinese medicinal materials. In order to raise awareness of correctly citation and maintain the authority and standardization of Chinese Pharmacopoeia, this paper briefly describes abbreviations rules of authors' name of plant scientific name according to the 'International Code of Botanical Nomenclature, ICBN'. Through comparing with the rules of ICBN, 'Flora of China' (Chinese edition and English edition), and authority international plant catalogue databases, the authors made statistic and analysis of the non-standard cited authors' names phenomena of the original plant scientific names recorded in the Chinese Pharmacopoeia (2010 edition), and the revision suggestions are proposed.
Asian Continental Ancestry Group ; Authorship ; China ; Databases, Factual ; Drugs, Chinese Herbal ; classification ; therapeutic use ; Humans ; Medicine, Chinese Traditional ; methods ; Pharmacopoeias as Topic ; standards ; Plants, Medicinal ; chemistry ; classification ; Reference Standards ; Terminology as Topic